Coq5 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
COQ5 Gene (Coenzyme Q Biosynthesis Factor 5) provides instructions for making the COQ5 protein, a mitochondrial methyltransferase essential for coenzyme Q (CoQ10) biosynthesis. The COQ5 protein catalyzes the C5-methylation step in the CoQ biosynthetic pathway, converting demethoxy-ubiquinone (DMQ) to intermediate forms that are subsequently processed to produce ubiquinone (CoQ10).
| Gene Symbol | COQ5 |
|---|
| Full Name | Coenzyme Q Biosynthesis Factor 5 |
|---|
| Chromosomal Location | 12q24.31 |
|---|
| NCBI Gene ID | 84223 |
|---|
| OMIM | 616787 |
|---|
| Ensembl ID | ENSG00000108465 |
|---|
| UniProt ID | Q9NXK5 |
|---|
The COQ5 gene contains:
- Exons: 6 coding exons
- Transcript length: ~1.2 kb coding sequence
- Protein length: 333 amino acids
- Molecular weight: ~38 kDa
COQ5 encodes a S-adenosylmethionine (SAM)-dependent methyltransferase that catalyzes:
- C5-methylation of demethoxy-ubiquinone (DMQ)
- Preparation of the intermediate for subsequent hydroxylation
- Essential step in CoQ10 ring modification
The COQ5 protein supports mitochondrial function by:
- Enabling CoQ10 synthesis - Essential electron carrier
- Supporting oxidative phosphorylation - ATP production
- Maintaining electron transport - Complex I and II function
- Antioxidant protection - CoQ10's role in ROS scavenging
COQ5 is expressed in various tissues:
- Brain - Neurons throughout the cerebral cortex, hippocampus, cerebellum
- Heart - High expression in cardiac muscle
- Liver - Metabolic activity
- Kidney - Renal tissue
- Muscle - Skeletal muscle
- Cerebral Cortex - Pyramidal neurons
- Hippocampus - CA1-CA3 neurons, dentate gyrus
- Cerebellum - Purkinje cells
- Basal Ganglia - Striatal neurons
- Substantia Nigra - Dopaminergic neurons
COQ5 mutations cause primary CoQ10 deficiency:
- Encephalomyopathy - Severe neurological impairment
- Ataxia - Cerebellar ataxia with coordination difficulties
- Myopathy - Muscle weakness, exercise intolerance
- Sensorineural hearing loss - Progressive deafness
- Nephropathy - Kidney disease in some cases
- Mitochondrial Complex I deficiency in PD substantia nigra
- CoQ10 levels reduced in PD brains
- Genetic variants may modify PD risk
- CoQ10 supplementation trials in PD
- Mitochondrial dysfunction in AD
- CoQ10 levels decline with age and AD
- Oxidative stress increased
- Therapeutic potential of CoQ10
- Energy metabolism deficits in ALS
- Mitochondrial dysfunction
- CoQ10 tested in clinical trials
- CoQ10 deficiency in some patients
- Mitochondrial defects
- Potential therapeutic target
| Treatment |
Mechanism |
Status |
| Ubiquinol (CoQ10) |
Electron carrier, antioxidant |
Supplements available |
| Idebenone |
Synthetic CoQ10 analog |
Approved for Friedreich's ataxia |
| MitoQ |
Mitochondria-targeted CoQ10 |
Research |
| CoQ10 nanoemulsions |
Improved bioavailability |
Clinical trials |
- Gene therapy to restore COQ5 function
- Small molecule CoQ pathway activators
- Mitochondria-targeted antioxidants
- Combination mitochondrial therapies
- Coq5 knockout mice - Embryonic lethal
- Yeast coq5 mutants - Require CoQ supplementation
- Zebrafish models - Show developmental defects
- C. elegans coq5 - Shortened lifespan
The study of Coq5 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Wang Y, et al. (2015). Human COQ5 is a mitochondrial protein required for CoQ biosynthesis. Biochim Biophys Acta 1851(10):1317-1329. PMID:26225998
- Stefely JA, et al. (2016). Mitochondrial COQ5 is phosphorylated by PKA. J Biol Chem 291(42):22522-22535. PMID:27605618
- Desbats MA, et al. (2015). Coenzyme Q biosynthesis in health and disease. Biochim Biophys Acta 1857(8):1079-85. PMID:25999232
- Hargreaves IP (2014). Coenzyme Q10 as a therapy for mitochondrial disease. Int J Mol Sci 15(5):8229-8243. PMID:24815075